Public Health News and Research

RSS

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications.

30 Nov 2015

Mexico Healthcare and Life Sciences Report 2015 released by Pharmaboardroom

Pharmaboardroom releases its new 98-page Mexico Healthcare and Life Sciences Report 2015. It offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the second largest pharma and healthcare market in Latin America, a country of over 122 million people.

30 Nov 2015

Lack of direct parental care affects brain development in left-behind children

Researchers in China have found that children who have been left without direct parental care for extended periods of time show larger gray matter volumes in the brain, according to a study being presented today at the annual meeting of the Radiological Society of North America.

30 Nov 2015

Structured personal diabetes care improves outcomes in women

A follow-up study to assess the effects of personally tailored diabetes care in general practice has revealed that such care reduces mortality (both all-cause and diabetes-related), in women, but not men. The study is by Dr Marlene Krag, The Research Unit for General Practice, Department of Public Health, University of Copenhagen, Denmark, and colleagues, and is published in Diabetologia, the journal of the European Association for the Study of Diabetes.

27 Nov 2015

Obese children with NAFLD not meeting recommended physical activity levels

In a new study published today in the journal Nutrients, research from the University of Surrey and the Children's Liver Disease Foundation has found that both obese children and those with Non-Alcoholic Fatty Liver Disease (NAFLD) are not meeting the UK recommendations for a variety of vitamins and minerals.

26 Nov 2015

Columbia University data scientists create world's first catalog of therapeutic venom

What doesn't kill you could cure you. A growing interest in the therapeutic value of animal venom has led a pair of Columbia University data scientists to create the first catalog of known animal toxins and their physiological effects on humans.

26 Nov 2015

Study: Mother Nature may help lower cholesterol levels in pregnant women

When it comes to effective solutions for lowering cholesterol levels in pregnant women, Mother Nature may know best.

26 Nov 2015

Researchers begin landmark clinical study to restore normal insulin secretion in people with type 1 diabetes

Investigators at Montreal's Lady Davis Institute at the Jewish General Hospital and McGill University Health Centre have announced the start of a landmark clinical study aimed at restoring normal insulin secretion in people with longstanding type 1 diabetes.

26 Nov 2015

Queen's University Belfast-led study examines potential of new technology that could save lives in ICUs

A potentially revolutionary new technology - that could saves thousands of lives in Intensive Care Units around the world - is being trialled in a UK study co-led by Queen's University Belfast.

26 Nov 2015

Ultrasound can help identify patients at increased risk of future stroke

Ultrasound, a non-invasive technique commonly used to study the presence of atherosclerosis disease in blood vessels, can be used to identify patients at increased risk of future stroke who could benefit from surgery. Since surgical treatment to prevent stroke is only considered beneficial to some, ultrasound can prove useful in preventing unnecessary surgical intervention, new research at Umeå University in Sweden shows.

25 Nov 2015

AF Association survey shows impact of AF diagnosis on patients

Atrial Fibrillation (AF) Aware Week aims to raise awareness of an important, yet not well understood heart rhythm disturbance. Taking place from the 23-29 November AF Aware Week increases awareness and understanding of AF amongst the general public. With AF effecting over a million people in the UK it is important that understanding of this condition is improved.

25 Nov 2015

Health insurance coverage for transgender people is cost-effective, study finds

A new analysis led by the Johns Hopkins Bloomberg School of Public Health suggests that while most U.S. health insurance plans deny benefits to transgender men and women for medical care necessary to transition to the opposite sex, paying for sex reassignment surgery and hormones is actually cost-effective.

25 Nov 2015

Women with moderate-to-severe PMS at increased risk of developing high blood pressure in later life

In the first prospective study to consider premenstrual syndrome (PMS) as a possible sentinel for future risk of hypertension, epidemiologist Elizabeth Bertone-Johnson and colleagues in the School of Public Health and Health Sciences at the University of Massachusetts Amherst and the Harvard School of Public Health report that women with moderate-to-severe PMS had a 40 percent higher risk of developing high blood pressure over the following 20 years compared to women experiencing few menstrual symptoms.

25 Nov 2015

First seasonal influenza vaccine containing adjuvant now approved by FDA

The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.

25 Nov 2015

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.

24 Nov 2015

Early childhood Medicaid exposure linked to adult health outcomes

Expanding publicly funded health insurance to low-income children could have long-term benefits for adult health, according to new research from the University of Maryland School of Public Health. Published in the Journal of Health Economics, the study found that exposure to Medicaid in early childhood, from conception through age 5, is associated with significant improvements in adult health (age 25 to 54).

24 Nov 2015

BioThrax approved to prevent disease after exposure to anthrax spores

The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.

24 Nov 2015

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

23 Nov 2015

New UMD study explores why African American and Hispanic women have high rates of unintended pregnancy

A new study from the University of Maryland School of Public Health examined why African American and Hispanic women have higher rates of unintended pregnancy than White women. Researchers found that there were unique factors explaining the differences in unintended pregnancy between African Americans and Whites (respondent's mother's age at first birth, income, and health insurance status) and the differences between Hispanics and Whites (U.S. born status and educational level).

23 Nov 2015

Prenatal smoking exposure can potentially affect someone's health for years after birth

New Johns Hopkins Bloomberg School of Public Health-led research finds that blood taken from children up to the age of five contains molecular evidence about whether their mothers smoked during pregnancy.

23 Nov 2015

Public Health News and Research

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Mexico Healthcare and Life Sciences Report 2015 released by Pharmaboardroom

Lack of direct parental care affects brain development in left-behind children

Structured personal diabetes care improves outcomes in women

Obese children with NAFLD not meeting recommended physical activity levels

Columbia University data scientists create world's first catalog of therapeutic venom

Study: Mother Nature may help lower cholesterol levels in pregnant women

Researchers begin landmark clinical study to restore normal insulin secretion in people with type 1 diabetes

Queen's University Belfast-led study examines potential of new technology that could save lives in ICUs

Ultrasound can help identify patients at increased risk of future stroke

AF Association survey shows impact of AF diagnosis on patients

Health insurance coverage for transgender people is cost-effective, study finds

Women with moderate-to-severe PMS at increased risk of developing high blood pressure in later life

First seasonal influenza vaccine containing adjuvant now approved by FDA

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

Early childhood Medicaid exposure linked to adult health outcomes

BioThrax approved to prevent disease after exposure to anthrax spores

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

New UMD study explores why African American and Hispanic women have high rates of unintended pregnancy

Prenatal smoking exposure can potentially affect someone's health for years after birth

News Medical 2025: Healthcare Shifts That Mattered Most eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News